期刊文献+

心内直视术患者围术期血清TNF-α水平动态变化及其临床意义 被引量:2

Perioperative Changes of Tumor Necrosis Factor Alpha and Its Action in Patients Undergoing Cardiopulmonary Bypass
暂未订购
导出
摘要 目的与方法:观察了40例择期心内手术患者及30例普外择期手术患者围术期血清TNF-α水平变化。结果:心内手术后2周内患者细胞免疫和红细胞免疫功能被明显抑制,而血清肿瘤坏死因子TNF-α明显升高,若合并严重感染后则进一步升高,但普外手术组上述参数变化与术前相比无统计学意义。心内手术术后严重感染率33%,MSOF发生率7.5%,而血清TNF-α水平与感染性并发症发生率呈正相关(P<0.01),普外手术组术后严重感染率仅6%。结论:心内手术后患者严重的细胞和红细胞免疫功能障碍是导致严重感染的最直接原因之一,而严重感染者血清TNF-α水平急剧升高是引发MSOF的机理之一。 bjective and Methods:A comparative study between the patients scheduled for cardiopulmonary bapass (CPB) and those underwent selective general surgary was carried out.Results: Experimenmtal data show that cell mediated and erythrocytic immunity were both siginificantly inhibited within two weeks after CPB,which was accompanied with a sharp rise of blood level of tumor necrosis factor alpha(TNF).The concentration of TNF alpha was increased to the highest level if the patient was complicated by severe infection.On the contrary,no statisical difference was discovered between preand postoperative values of the parameters mentioned above in general surgery group after operation.Serious infectious rate of 325%,morbility of multiple system organ failure(MSOF) of 75%,and a linear regression between serum level of TNF alpha and incidence of severe infection were observed in CPB group.Conversely,in general surgery group serious infection rate was only 6%.Conclusion:It is concluded that serious cellular and erythrocytic immunodepression is the direct reason for resulting in severe infection after CPB,and a high level of TNF alpha in serum is one of the mechanisms of MSOF.
出处 《临床麻醉学杂志》 CAS CSCD 1998年第1期5-7,共3页 Journal of Clinical Anesthesiology
基金 国家教委资助
关键词 肿瘤坏死因子 心脏外科手术 围手术期 Cardiopulmonary bypass Immunity Erythrocyte Tumor necrosis factor
  • 相关文献

参考文献10

  • 1Carrico GJ,Meakins JL,Marsall TG,et al. Multiple organ failure syndrome. Arch Surg, 1986,121 (3): 196.
  • 2Baue AE.eds. Multiple organ failure. 1st Ed. Industrial Drive. St. Louis: Mosby-Year Book Inc, 1990.250.
  • 3Hisatomic K,Isornura T,Kawara T,et al. Changes in lymphocyte subset, mitogen responsiveness, and interleukin-2 production after cardiac operation. J Thorac Cardiovas Surg,1989,98:580.
  • 4Markeritz A, Falst E, Larg S, et al. Successful restoration of cell rnediated immune response after cardiopulmonary bapass by immunodulation. J Thorac Cardiovas Surg, 1993,105:15.
  • 5张延龄.多系统器官衰竭病因的近代研究[J].国外医学(创伤与外科基本问题分册),1993,14(3):130-134. 被引量:4
  • 6Roth JA ,Golub SH,Cukingnom RA ,et al. Cell-me-diated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg, 1990,31: 350.
  • 7Von Oeveren W, Kazatchkine MD, Descamps-Lat-sha B, et al. Deleterious effects of cardiopulmonary bypass. J Thorac Cardiovas Surg, 1985,89 :888.
  • 8Oppenheim J J, Shevach EM. Immunophysiology.New York :Oxford University Press,227.
  • 9Fosse E,Mollnes TE,Ingvaldsen B,et al. Complement activation during major operation with cardiopulmonary bypass. J Thorac Cardlovas Surg,1987,93:860.
  • 10Howard RJ,Crain C,Franzini DA,et al. Effects of cardipopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg, 1988,123:1496.

共引文献3

同被引文献33

引证文献2

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部